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Abstract 
Nitric oxide (‘NO) release, oxygen uptake and hydrogen peroxide (H202) production elicited by increasing phorbol12-myristate 13-acetate (PMA) 
concentrations were measured in human neutrophils. Half-maximal activities were sequentially elicited at about 0.0001-0.001 pg PMA/ml CNO) and 
O.OOl~.Ol pg PMA/ml (H,OJ. At saturated PMA concentrations, ‘NO production, oxygen uptake and H,O, release were 0.56 ? 0.04, 3.32 f 0.52 
and 1.19 f 0.17 nmol min-’ 1 O6 cells-‘. ‘NO production accounts for about 30% of the total oxygen uptake. Luminol-dependent chemiluminescence, 
reported to detect NO reactions in other inflammatory cells, was also half-maximally activated at about 0.00-0.01 pg PMA/ml. Preincubation with 
A’“-monomethyl-L-arginine (L-NMMA) decreased 0, uptake and ‘NO release but increased H,Oz production, while superoxide dismutase (SOD) 
increased ‘NO detection by 30%. Chemiluminescence was also reduced by preincubation with L-NMMA and/or SOD. The results indicate that ‘NO 
release is part of the integrated response of stimulated human neutrophils and that, in these cells, kinetics of-NO and O;- release favour the formation 
of other oxidants like peroxynitrite. 
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1. Introduction 
Human neutrophils (PMN) exposed to soluble or par- 
ticulate stimuli undergo a large increase in cyanide-insen- 
sitive oxygen consumption termed the respiratory burst 
[ 1,2]. Several authors demonstrated that superoxide 
anion (O;-) and hydrogen peroxide (H202) are produced 
and that these compounds are apparently responsible for 
the microbicidal activity of PMN [3,4]. 
It has recently been shown that circulating human 
neutrophils release nitric oxide (‘NO) when they are ex- 
posed to appropriate stimuli by activation of a constitu- 
tive nitric oxide synthase (cNOS), while inflammatory 
(emigrated) neutrophils express an inducible nitric oxide 
synthase [5-81. Several reports suggest that the nitric 
oxide pathway interacts with the respiratory burst of 
activated rat peritoneal neutrophils and other inflamma- 
tory cells [9, lo]. Simultaneous production of-NO and O;- 
may form peroxynitrite which could mediate nitric 
oxide-dependent microbe killing by phagocytic cells, as 
was recently described for rat macrophages [l 1,121; it 
remains to be seen whether this interaction can be repro- 
duced by activated human neutrophils. 
In this report, we describe the kinetics of nitric oxide 
release during respiratory burst of human neutrophils 
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stimulated with PMA, and relate it to the simultaneous 
production of reactive oxygen species in order to assess 
possible interactions between these radicals. 
2. Materials and methods 
2.1. Preparation of human neutrophils 
Heparinized venous blood was drawn from healthy volunteers. 
Human neutrophils were isolated by Ficoll-Hypaque gradient centri- 
fugation, dextran sedimentation and hypotonic lysis of contaminant 
erythrocytes [13]. The cells were resuspended in 120 mM NaCl, 5 mM 
KCl, 1.9 mM KH,PO,, 1.1 mM Na,HPO, . 12H,O, 0.3 mM MgSO, 
7H,O, 1 mM MgCl,, 1 mMCaCl,, 4.2 mM NaHCO,, 20 mM HEPES 
and 5.5 mM glucose, pH 7.4 (HBSS). Cell preparations consisted of 
about 98% of viable neutrophils (Trypan blue test). 
2.2. Oxygen consumption 
Oxygen consumption was measured with a Clark type oxygen elec- 
trode at 30°C [14]. PMN were placed in a thermostatted chamber at 
2 x lo6 cells/ml in HBSS. The rate of oxygen consumption was calcu- 
lated from the linear trace initiated by addition of PMA to the incuba- 
tion medium and expressed in nmol 0, min-’ . lo6 cells-‘. 
2.3. Hydrogen peroxide generation 
Hydrogen peroxide was continuously measured by the horseradish 
peroxidase (HRP)/p-hydroxyphenyl acetic acid (pHPA) assay at 30°C 
with a Hitachi F 3010 spectrofluorimeter [15]. The reaction medium 
contained HBSS, 5 U/ml HRP, 40 PM pHPA and lo6 cells. Hydrogen 
peroxide generation was calculated from a standard curve made with 
titrated H202 solutions and was expressed in nmol min-’ lo6 cells-‘. 
2.4. Nitric oxide production 
‘NO production was measured by the oxidation of oxymyoglobin 
(oxyMb) to metmyoglobin (metMb) in a double beam-double wave- 
length 356 Perkin-Elmer spectrophotometer [16]. The absorbance dif- 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00139-M 
66 M. C. Carreras et al. I FEBS Letters 341 (I 994) 65t?X 
ference at 581-593 nm was continuously monitored at 30°C and the 
rate of ‘NO formation was calculated by using the extinction coefficient 
11.6 mM_’ cm-’ and expressed as nmol min-’ 1 O6 cells-‘. The reac- 
tion medium contained 20 PM oxyhlb, HBSS and lo6 cells/ml. 
Oxymyoglobin was prepared by reduction of metMb with sodium hy- 
drosulphite followed by gel filtration in a prepacked Sephadex G-25 
column previously equilibrated with 50 mM potassium phosphate 
buffer at pH 7.4. The concentration of oxyMb was determined spectro- 
photometrically [171. 
The eventual contribution of hydrogen peroxide to oxyMb decay was 
assayed in the presence of non-stimulated PMN and glucose oxidase/ 
glucose producing 1 nmol H,O,/min. OxyMb decay accounted for less 
than 10% of the rate of H,O1 production. 
To study possible radical interactions, ‘NO and H,Or release were 
measured after preincubation with 1 mM L-NMMA for 30 min. 
2.5. Luminol-dependent chemiluminescence 
Luminol-dependent chemiluminescence was measured with a C-660 
computerized Thorn EM1 (UK) photon counter at 30°C [18]. The 
reaction medium contained HBSS, 5 PM luminol and 5 x 10’ cells/ml. 
To assess a possible contribution of ‘NO reactions on chemilumines- 
cence, the experiments were repeated with 100 U/ml SOD and 1 mM 
L-NMMA. 
2.6. Materials 
All chemicals were purchased from Sigma Chemical Co. 
2.7. Statistical analysis 
Statistical differences were assessed with paired Student’s t-test; all 
differences were considered significant when P < 0.05. 
3. Results 
3.1. Oxygen consumption and hydrogen peroxide 
production 
Upon exposure of human neutrophils to several PMA 
concentrations, oxygen uptake and H202 release in- 
creased in a dose-dependent manner up to 0.1-l ,ug 
PMA/ml. Oxygen consumption rates increased from 
the basal unstimulated value (0.56 ? 0.03 nmol 
OZ. min-’ . lo6 cells-‘) up to maximal plateau rates at 
0.1-l pug PMA/ml (3.32 f 0.52 nmol OZ. min-’ . lo6 
cells-‘; Fig. 1). 
Hydrogen peroxide production was detected at 0.001 
pg PMA/ml and increased up to 1.19 f 0.17 nmol H,Oz 
. min-’ . lo6 cells-’ at 0.1-l ,ug PMA/ml (Fig. 2). The 
half-maximal stimulatory effects of oxygen uptake and 
hydrogen peroxide production were observed between 
0.001 and 0.01 pg PMA/ml. Preincubation with or with- 
out 1 mM L-NMMA for 30 min at 37°C depressed oxy- 
gen uptake but, conversely, increased the H202 genera- 
tion rate, P < 0.05 (Table 1). 
3.2. Nitric oxide production 
*NO production by human neutrophils was increased 
by addition of PMA; the effect was noticeable at very 
low PMA concentrations (0.0001 ,ug PMA/ml), and in- 
creased up to a maximal rate of 0.56 + 0.08 nmol NO 
. min-’ . lo6 cells-’ at 0.01 ,ug PMA/ml. The half-max- 
imal effect was observed between 0.0001 and 0.001 ,ug 
PMA/ml (Fig. 2). Preincubation with L-NMMA dimin- 
ished *NO production by about 50%: P c 0.005 (Table 
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Fig. 1. Oxygen consumption by human neutrophils stimulated with 
PMA. Values are mean f S.E.M. from 6 experiments. 
1). The addition of 100 U/ml SOD produced an increase 
in ‘NO detection of about 30% at 0.1 ,ug PMA/ml, 
P c 0.01 (Fig. 3). 
3.3. Luminol-induced chemiluminescence 
Addition of PMA also increased the luminol-depend- 
ent chemiluminescence, reaching a half-maximal effect 
between 0.001 and 0.01 ,ug PMA/ml and a maximal rate 
at 0.1-l ,ug PMA/ml (Fig. 2, inset). Preincubation with 
L-NMMA decreased chemiluminescence yield by 50% 
(Table 1) and the addition of 100 U SOD/ml further 
diminished it by 70% (control 111 I!I 13 vs. SOD 36 + 5 
cps . lo6 cells-‘: P c 0.01) thus suggesting that the NOS 
pathway contributed to luminol-sensitized chemilumi- 
nescence of activated human neutrophils. 
4. Discussion 
According to these results, nitric oxide is generated 
together with superoxide anion and hydrogen peroxide 
during the respiratory burst of polymorphonuclear leu- 
cocytes. However, some differences between the kinetics 
of ‘NO and H20, generation are observed. First, ‘NO 
release starts at PMA concentrations lower than those 
that elicited detectable H,O, increase, with half-maximal 
effects at about 0.001 ,ug PMA/ml for ‘NO and 0.01 pg 
PMA/ml for oxygen uptake and H,02 production. Thus, 
it appears to be an early and sensitive indicator of trig- 
gering of the respiratory burst by phorbol esters. Addi- 
tionally, the rate of ‘NO production and probably the 
activity of cNOS in neutrophils reached a ‘plateau’ ear- 
lier than NADPH oxidase. There was no further increase 
at PMA concentrations above 0.01 &ml. This strongly 
suggests an organized and sequential pathway for activa- 
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Fig. 2. Nitric oxide and hydrogen peroxide production by human neu- 
trophils stimulated by PMA. Values are mean f S.E.M. from 5-7 sam- 
ples. Inset: luminol-dependent chemiluminescence (CL) by human neu- 
trophils stimulated with PMA. 
tion of cNOS and NADPH oxidase by protein kinase C 
stimulators like PMA. 
In our experimental conditions, ‘NO production ac- 
counts for about 30% of the total oxygen uptake of 
maximally stimulated neutrophils. In this line, Ischirou- 
poulos et al. [l l] reported that inhibition of nitric oxide 
synthesis decreased oxygen uptake by 20% in stimulated 
macrophages. 
Nitric oxide and superoxide radicals can react in a 
second-order eaction: 
l NO + 0-i + ONOO- (1) 
In our case, the data seem to indicate that ‘NO and O;- 
generated simultaneously during the respiratory burst, 
are kinetically able to react to form peroxynitrite. In 
agreement with this view, the incubation of PMN with 
SOD showed that at least 0.2 nmol ‘NO. rnin-’ . lo6 
cells-’ are converted to peroxynitrite at 0.1 pg PMA/ml 
(Fig. 3); in the same way, L-NMMA increased H,O, 
production by about 0.3 nmol . min-’ . lo6 cells-’ (Table 
1). This rate of peroxynitrite formation (0.2 mnol . min-’ 
. lo6 cells-‘) similar to that reported by Ischiroupoulos 
et al. for rat alveolar macrophages [l 11. 
Luminol-dependent chemiluminescence by PMN re- 
flects a complex co-oxidative process; excitation of lumi- 
no1 is currently attributed to hypochlorous acid-H,O, 
[18], but recently, it was shown that OONO- might con- 
tribute to light emission [19,20]. In this system, neither 
‘NO nor O;- alone is capable of directly inducing signif- 
icant chemiluminescence yield [ 191. The ‘NO derived in- 
termediates contribute to luminol chemiluminescence in
other cells like PMA-activated Kupffer cells and rat mac- 
rophages and may react via ONOO- [20,21]. In this 
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work, the dependence of chemiluminescence on PMA 
concentrations (Fig. 2, inset) and, the fact that it was 
inhibited by L-NMMA and SOD suggest OONO- forma- 
tion in the human PMN respiratory burst. In contrast, 
HOC1 should be the main determinant of luminol chem- 
iluminescence in other cells like rat granulocytes where 
NO is released in minor quantities, if at all [21]. 
The reaction of O;- with *NO yielding peroxynitrite 
(reaction 1) has been reported to proceed in aqueous 
solution at a constant rate of 3.7 x lo7 M-’ . se1 [22]; 
however, recent evidence suggests that this rate constant 
might be 200-fold higher, almost diffusion controlled, 
and similar to that of the gas phase reaction of HOi with 
‘NO (6.7 x lo9 M-’ . s-‘) [23]. Considering this value, it 
is apparent hat all ‘NO generated by neutrophils should 
be converted to ONOO- so that, from 0.01 ,ug PMA/ml, 
O;- and H,Oz production rates should determine the max- 
imal ONOO- levels. Nevertheless, it is possible that the 
rate constant for ONOO- formation is somewhat lower 
in biological systems; indeed, SOD catalyzed dismuta- 
tion of 0; to H,02 with a rate constant of 2 x lo9 
M-’ . SC’ [24] competes with reaction 1 (Fig. 3). Possi- 
ble discrepancies between total ‘NO and ONOO- for- 
mation with human neutrophils could be due to the 
prompt conversion of ONOO- to ‘NO, and ‘OH or to 
NO;;,.Radi et al. reported rapid exponential decay of 
ONOO- induced chemiluminescence following first- 
order kinetics [ 191. Other reactions such as conversion of 
‘NO to NO- by SOD or NADPH oxidase could also 
affect final ONOO- levels [11,16]. 
The biological significance of the simultaneous pro- 
duction of O;- and ‘NO in PMN is not clear at the present 
time. However, Malawista et al. [25] showed that reactive 
nitrogen intermediates participate in the killing of staph- 
ylococci by human neutrophil cytoplasts; Marletta et al. 
Table 1 
Effect of L-NMMA on oxygen consumption, ‘NO and H,02 production 
and luminol-dependent chemiluminescence byPMA-stimulated human 
neutrophils 
PMA - L-NMMA + 1 mM 
Wml) L-NMMA 
Oxygen consumption _ 0.56 f 0.03 0.50 f 0.05 
(nmol/min/106 cells) 0.1 3.98 f 0.27 2.97 I! 0.28* 
NO production _ 0.08 + 0.01 0.05 k 0.01 
(nmol/min/106 cells) 0.1 0.58 k 0.04 0.28 f 0.04* 
H,02 production _ ND ND 
(nmol/min/106 cells) 0.1 1.19 f 0.17 1.52 + 0.19* 
Luminol-dependent chemi- - 21 f2 12 + 2 
luminescence (cps/106 cells) 0.1 111 f 13 59 + 5*** 
The PMN were preincubated for 30 min at 37°C with or without 1 mM 
L-NMMA. Values are mean f S.E.M. of 46 experiments. ND, not 
detectable. 
*P < 0.05; **p < 0.005; ***p < 0.025. 
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Fig. 3. Effect of superoxide dismutase on nitric oxide detection by PMA 
stimulated human neutrophils. Values are mean + S.E.M. from 3-4 
samples with (filled circles) or without 100 U SOD/ml (open circles). 
[26] related ‘NO production to microbicidal and tumori- 
tidal activity of macrophages; Zhu et al. [12] showed the 
bactericidal activity of peroxynitrite on Escherichia coli 
cultures and Radi et al. [27] demonstrated the ability of 
peroxynitrite to kill T cruzi. Moreover, Mulligan et al. 
[28-301 showed that inhibition of nitric oxide synthesis 
with L-NMMA reduced inmune complex-induced injury. 
Finally, we suggest hat ‘NO production by cNOS is 
a part of the integrated neutrophil response and that the 
kinetics of simultaneous ‘NO and O;- production favour 
the formation of peroxynitrite. This process, a general 
feature of the chemistry of phagocytes, can be involved 
either in defence mechanisms or in neutrophil-mediated 
tissue injury. 
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